Abstract:Background There is evidence from epidemiological and in vitro studies that the biological effects of testosterone (T) on cell cycle and survival are modulated by 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) in prostate cancer. To investigate the cross talk between androgen- and vitamin D-mediated intracellular signaling pathways, the individual and combined effects of T and 1,25(OH) 2 D 3 on global gene expression in LNCaP prostate cancer cells were assessed. Results Stringent statistical analysis identifies a cohort of genes that lack one or both androgen response elements (AREs) or vitamin D response elements (VDREs) in their promoters, which are nevertheless differentially regulated by both steroids (either additively or synergistically). This suggests that mechanisms in addition to VDR- and AR-mediated transcription are responsible for the modulation of gene expression. Microarray analysis shows that fifteen miRNAs are also differentially regulated by 1,25(OH) 2 D 3 and T. Among these miR-22, miR-29ab, miR-134, miR-1207-5p and miR-371-5p are up regulated, while miR-17 and miR-20a, members of the miR-17/92 cluster are down regulated. A number of genes implicated in cell cycle progression, lipid synthesis and accumulation and calcium homeostasis are among the mRNA targets of these miRNAs. Thus, in addition to their well characterized effects on transcription, mediated by either or both cognate nuclear receptors, 1,25(OH) 2 D 3 and T regulate the steady state mRNA levels by modulating miRNA-mediated mRNA degradation, generating attenuation feedback loops that result in global changes in mRNA and protein levels. Changes in genes involved in calcium homeostasis may have specific clinical importance since the second messenger Ca 2+ is known to modulate various cellular processes, including cell proliferation, cell death and cell motility, which affects prostate cancer tumor progression and responsiveness to therapy. Conclusions These data indicate that these two hormones combine to drive a differentiated phenotype, and reinforce the idea that the age dependent decline in both hormones results in the de-differentiation of prostate tumor cells, which results in increased proliferation, motility and invasion common to aggressive tumors. These studies also reinforce the potential importance of miRNAs in prostate cancer progression and therapeutic outcomes.

CMTM3 Can Affect the Transcription Activity of Androgen Receptor and Inhibit the Expression Level of PSA in LNCaP Cells.

CMTM1-v17, a New Potential Corepressor of Androgen Receptor

Human CMTM2/CKLFSF2 enhances the ligand-induced transactivation of the androgen receptor

AB179. CMTM3 is Reduced in Prostate Cancer and Inhibits Migration, Invasion and Growth of LNCaP Cells

CMTM3 Inhibits Human Testicular Cancer Cell Growth Through Inducing Cell-Cycle Arrest and Apoptosis

Function of CMTM2 in Male Reproductive System

Characterization and expression profile of CMTM3/CKLFSF3.

Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells

Long Noncoding RNA TCONS_00027385 Acts as a miR-874-5p Sponge to Suppress the Progression of Prostate Cancer Through Regulating ASCC2 Expression

CMTM3 is Frequently Reduced in Clear Cell Renal Cell Carcinoma and Exhibits Tumor Suppressor Activities

CMTM3 Suppresses Proliferation and Osteogenic Transdifferentiation of C2C12 Myoblasts through p53 Upregulation

Hypermethylation-mediated Transcriptional Repression of TMPRSS2 in Androgen Receptor-Negative Prostate Cancer Cells

Cmtm3, Located At The Critical Tumor Suppressor Locus 16q22.1, Is Silenced By Cpg Methylation In Carcinomas And Inhibits Tumor Cell Growth Through Inducing Apoptosis

[CMTM5 Inhibits the Tumor Cell Behavior of Prostate Cancer by Downregulation of HER2].

CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo

[Knockdown of CMTM3 Promotes Migration and Invasion of PC3 Cell in Vitro].

Research Advances in CKLFSF-like MARVEL Transmembrane Domain Containing Member 3.

Data from <i>CMTM3</i>, Located at the Critical Tumor Suppressor Locus 16q22.1, Is Silenced by CpG Methylation in Carcinomas and Inhibits Tumor Cell Growth through Inducing Apoptosis

LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration

Effect of CMTM5 on Prostate Cancer Cell Proliferation, Migration and Invasion

CMTM5-v1 inhibits cell proliferation and migration by downregulating oncogenic EGFR signaling in prostate cancer cells